发明名称 Amphiphilic polysaccharide derivatives
摘要 Polysaccharides, which are widely used as anticoagulation drugs, especially heparin, are clinically administered only by intravenous or subcutaneous injection because of their strong hydrophilicity and high negative charge. Amphiphilic heparin derivatives were synthesized by conjugate to bile acids, sterols, and alkanoic acids, respectively. The hydrophobicity of the heparin derivatives depended on the feed mole ratio of heparin to hydrophobic agent. The heparin derivatives were slightly hydrophobic and exhibited good solubility in a water-acetone solvent, as well as water. The heparin derivatives have a high anticoagulant activity. These slightly hydrophobic heparin derivatives can be absorbed in gastric intestinal tract and can be used as oral dosage form. Also, the heparin derivatives can be used for the surface modification to prevent coagulation for medical devices such as extracorporeal devices and implanted devices.
申请公布号 AU3735899(A) 申请公布日期 1999.12.13
申请号 AU19990037358 申请日期 1999.05.14
申请人 MEDIPLEX CORPORATION, KOREA 发明人 YOUNGRO BYUN;YONG KYU LEE
分类号 A61K47/32;A61K31/717;A61K31/727;A61K31/737;A61K47/34;A61K47/42;A61K47/48;A61L33/10;A61P7/02;C08B15/00;C08B37/00;C08B37/10 主分类号 A61K47/32
代理机构 代理人
主权项
地址